Works matching AU Achiron, Anat


Results: 115
    1
    2
    3

    Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231194823
    By:
    • Coles, Alasdair J.;
    • Achiron, Anat;
    • Traboulsee, Anthony;
    • Singer, Barry A.;
    • Pozzilli, Carlo;
    • Oreja-Guevara, Celia;
    • Giovannoni, Gavin;
    • Comi, Giancarlo;
    • Freedman, Mark S.;
    • Ziemssen, Tjalf;
    • Shiota, Debora;
    • Rawlings, Andreea M.;
    • Wong, Alana T.;
    • Chirieac, Magdalena;
    • Montalban, Xavier
    Publication type:
    Article
    4

    Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231194823
    By:
    • Coles, Alasdair J.;
    • Achiron, Anat;
    • Traboulsee, Anthony;
    • Singer, Barry A.;
    • Pozzilli, Carlo;
    • Oreja-Guevara, Celia;
    • Giovannoni, Gavin;
    • Comi, Giancarlo;
    • Freedman, Mark S.;
    • Ziemssen, Tjalf;
    • Shiota, Debora;
    • Rawlings, Andreea M.;
    • Wong, Alana T.;
    • Chirieac, Magdalena;
    • Montalban, Xavier
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation.

    Published in:
    Annals of Neurology, 2012, v. 71, n. 4, p. 509, doi. 10.1002/ana.22684
    By:
    • Blumen, Sergiu C.;
    • Astord, Stéphanie;
    • Robin, Valérie;
    • Vignaud, Ludivine;
    • Toumi, Nawel;
    • Cieslik, Aurore;
    • Achiron, Anat;
    • Carasso, Ralph L.;
    • Gurevich, Michael;
    • Braverman, Itzhak;
    • Blumen, Nava;
    • Munich, Arnold;
    • Barkats, Martine;
    • Viollet, Louis
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.

    Published in:
    Multiple Sclerosis Journal, 2013, v. 19, n. 11, p. 1533, doi. 10.1177/1352458513477925
    By:
    • Olsson, Tomas;
    • Achiron, Anat;
    • Alfredsson, Lars;
    • Berger, Thomas;
    • Brassat, David;
    • Chan, Andrew;
    • Comi, Giancarlo;
    • Eraksoy, Mefkure;
    • Hegen, Harald;
    • Hillert, Jan;
    • Jensen, Poul Erik Hyldgaard;
    • Moiola, Lucia;
    • Myhr, Kjell-Morten;
    • Oturai, Annette;
    • Schippling, Sven;
    • Siva, Aksel;
    • Sorensen, Per Soelberg;
    • Trampe, Anne-Kathrin;
    • Weber, Thomas;
    • Potts, James
    Publication type:
    Article
    24
    25

    Late-Onset Multiple Sclerosis.

    Published in:
    Journal of the American Geriatrics Society, 2001, v. 49, n. 2, p. 168, doi. 10.1046/j.1532-5415.2001.49038.x
    By:
    • Polliack, Michael Leon;
    • Barak, Yoram;
    • Achiron, Anat
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Happiness and neurological diseases.

    Published in:
    Expert Review of Neurotherapeutics, 2009, v. 9, n. 4, p. 445, doi. 10.1586/ern.09.1
    By:
    • Barak, Yoram;
    • Achiron, Anat
    Publication type:
    Article
    40

    COMMENTARIES.

    Published in:
    International Journal of Therapy & Rehabilitation, 2003, v. 10, n. 9, p. 416
    By:
    • Achiron, Anat;
    • Harel, Yermi
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50